These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 9617599

  • 1. Moexipril. A review of its use in the management of essential hypertension.
    Brogden RN, Wiseman LR.
    Drugs; 1998 Jun; 55(6):845-60. PubMed ID: 9617599
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause.
    Agabiti-Rosei E, Ambrosioni E, Pirelli A, Stimpel M, Zanchetti A.
    Eur J Clin Pharmacol; 1999 May; 55(3):185-9. PubMed ID: 10379633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Moexipril versus captopril in patients with mild to moderate hypertension.
    Stimpel M, Koch B, Jansen T, Fox A, Loh I.
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):769-73. PubMed ID: 8961074
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
    White WB, Koch B, Stimpel M.
    Am J Ther; 1997 Apr; 4(4):123-9. PubMed ID: 10423601
    [Abstract] [Full Text] [Related]

  • 6. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
    White WB, Stimpel M.
    J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H, Ney P.
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
    Stimpel M, Koch B, Oparil S.
    Cardiology; 1998 May; 89(4):271-6. PubMed ID: 9643274
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological and clinical profile of moexipril: a concise review.
    Chrysant SG, Chrysant GS.
    J Clin Pharmacol; 2004 Aug; 44(8):827-36. PubMed ID: 15286086
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.
    Stimpel M, Koch B, Weber MA.
    Maturitas; 1998 Sep 20; 30(1):69-77. PubMed ID: 9819786
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG, Fox AA, Stimpel M.
    Am J Hypertens; 1995 Apr 20; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring.
    White WB, Whelton A, Fox AA, Stimpel M, Kaihlanen PM.
    J Clin Pharmacol; 1995 Mar 20; 35(3):233-8. PubMed ID: 7608310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Moexipril as add-on therapy to hydrochlorothiazide in moderate to severe hypertension.
    Stimpel M, Koch B, Dickstein K.
    Cardiology; 1996 Mar 20; 87(4):313-8. PubMed ID: 8793166
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.